Neuropsychiatric assessment as a secondary outcome measure in a multiple sclerosis intravenous immunoglobulin L(IMg) trial. [electronic resource]
Producer: 20140621Description: 31-4 p. digitalISSN:- 1365-1501
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.